Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 111 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 548.05 USD | +1.44% | +8.77% | +14.33% | +38.57% | 138.91 B USD | ||
| 197 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 834.04 USD | +0.90% | +4.03% | +25.93% | +41.11% | 85.87 B USD | ||
| 263 |  ARGX argenx SE - American Depositary Shares | 1039.78 USD | +0.16% | +12.13% | +13.64% | +51.67% | 64.35 B USD | ||
| 288 |  MRNA Moderna, Inc. - Common Stock | 145.13 USD | +8.86% | +125.88% | +164.64% | +435.14% | 57.94 B USD | ||
| 352 |  RVMD Revolution Medicines, Inc. - Common Stock | 209.46 USD | -1.08% | +2.67% | +10.88% | +278.09% | 44.89 B USD | ||
| 445 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.22 USD | +3.02% | +4.63% | -13.94% | -47.90% | 31.61 B USD | ||
| 477 |  BNTX BioNTech SE - American Depositary Shares | 116.57 USD | +5.12% | +25.05% | +30.27% | +5.14% | 27.97 B USD | ||
| 484 |  INSM Insmed Incorporated - Common Stock | 125.77 USD | +0.55% | +0.85% | +17.51% | -22.39% | 27.47 B USD | ||
| 488 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.31 USD | +1.21% | +5.05% | +4.22% | +64.55% | 27.38 B USD | ||
| 505 |  ROIV Roivant Sciences Ltd. - Common Shares | 36.30 USD | -1.47% | +0.22% | +3.21% | +98.25% | 26.22 B USD | ||
| 508 |  INCY Incyte Corporation - Common Stock | 127.81 USD | +0.46% | +6.37% | +8.62% | +50.36% | 25.91 B USD | ||
| 575 |  UTHR United Therapeutics Corporation - Common Stock | 513.12 USD | -1.51% | +2.22% | -3.13% | +65.14% | 22.01 B USD | ||
| 676 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 254.28 USD | +2.24% | +3.83% | -0.20% | +81.63% | 16.51 B USD | ||
| 687 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 81.50 USD | -1.74% | +2.97% | -3.02% | +42.98% | 15.93 B USD | ||
| 696 |  ASND Ascendis Pharma A/S - American Depositary Shares | 253.29 USD | -0.60% | +2.80% | -0.89% | +23.51% | 15.70 B USD | ||
| 773 |  EXEL Exelixis, Inc. - Common Stock | 54.08 USD | +0.73% | +5.52% | -3.10% | +38.52% | 13.40 B USD | ||
| 779 |  CORT Corcept Therapeutics Incorporated - Common Stock | 122.25 USD | +0.99% | +6.30% | +33.46% | +66.62% | 13.22 B USD | ||
| 794 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.70 USD | -1.45% | -0.45% | +11.37% | +13.28% | 12.91 B USD | ||
| 818 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 87.11 USD | -0.41% | +0.78% | +1.30% | +122.79% | 12.30 B USD | ||
| 821 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 108.17 USD | +1.93% | +9.42% | +31.26% | +61.93% | 12.28 B USD |
Nachrichten Biotechnology Stocks
GRI Bio präsentiert Phase-2a-Studiendaten zu Lungenfibrose-Wirkstoff auf ERS-Kongress
Alnylam präsentiert auf ESC-Kongress neue Daten zu Medikamenten gegen ATTR-Amyloidose und Bluthochdruck
FibroBiologics beruft Sport-Agenten-Legende Leigh Steinberg in den Verwaltungsrat
Lexicon erhält 10-Millionen-Dollar-Meilensteinzahlung von Novo Nordisk für Adipositas-Wirkstoff
BioCardia erhält FDA-Bestätigung für Zulassungspläne des Helix-Katheters
Humacyte plant für November FDA-Zulassungsantrag für Dialysezugang
Spruce Biosciences schließt wichtige FDA-Gespräche für Therapie des Sanfilippo-Syndroms ab
Gainers Biotechnology Stocks
 LIMN Liminatus Pharma, Inc. - Class A Common Stock | 5.15 | +4581.82% |
 SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.22 | +1010.34% |
 ELAB PMGC Holdings Inc. - Common Stock | 6.66 | +991.80% |
 HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.87 | +102.33% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.55 | +38.39% |
 NTRBW Nutriband Inc. - Warrant | 0.5000 | +25.06% |
 ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 13.45 | +22.38% |
Losers Biotechnology Stocks
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0010 | -52.38% |
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 XCUR Exicure, Inc. - Common Stock | 1.15 | -11.54% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.39 | -11.36% |
 CURX Curanex Pharmaceuticals Inc - Common Stock | 4.71 | -10.63% |
 HURA TuHURA Biosciences, Inc. - Common Stock | 2.00 | -9.91% |